New drug cocktail targets superbug pneumonia in hospitals
NCT ID NCT07326540
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study tests a new combination of antibiotics (BV100 plus low-dose polymyxin B) against a standard treatment for a serious lung infection caught in the hospital. The infection is caused by bacteria that are resistant to many current drugs. About 248 adults will take part to see if the new combo reduces deaths and cures the infection better than the standard approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL ACQUIRED BACTERIAL PNEUMONIA (HABP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital
RECRUITINGTbilisi, Georgia
Conditions
Explore the condition pages connected to this study.